Accelerated plan with CEO (Senior Scientist/Physician) and CTO co-founders to stand up SaaS biotech startup delivering immunization programs and tracking for individuals and public health orgs. Spun initial funding via mHealth Lab partnership to be revenue positive in first 6 months of launch and achieved $MM in revenue in 18 months; structured equity, share capital, and due diligence; managed P&L and Board reporting. Partnered with Canada’s Public Health leadership across Provinces and private global enterprise partners to launch product initiatives.Directed Operations, managing director-level department heads across Customer Support, Sales, Legal, Privacy, HR, Finance, and Insurance; scaled org to 70 employees. Recruited Customer Success team of 20, building product implementation, ticketing, and reporting processes; drove Sales and CS team performance with coaching, individual and team target setting, and compensation programs. Facilitated privacy, terms of use, information security, and compliance policies; partnered with Legal and Privacy Officers; led complex spin-out from mHealth and Ottawa Hospital Research Institute.

Promoted by CEO and Institute Board to stand up and launch Ottawa Hospital’s mHealth Lab; co-founded the biotech lab and SaaS product offering with Senior Scientist. Created 8 healthcare product initiatives to deliver solutions combining science, software development, diagnostic algorithms, and human-centered design to transform healthcare technology and patient outcomes. Garnered 400,000 app downloads by Y2 of product launch; recognized by European Center for Disease Prevention & Control as a model for public-facing immunization solutions; approved by WHO Vaccine SafetyNet; identified as a Health Standards Organization leading practice. Defined research and business development functions; managed due diligence and opportunity cost to build product conceptualization, lab operations, grants application development, reporting, and evaluation. Built impact frameworks to support closing and managing $MM in funding from partners including Gates Foundation, Public Health Agency, Toronto Transplant Institute, Crohn’s & Colitis Canada, Sanofi, and Pfizer.